191 related articles for article (PubMed ID: 6386990)
21. A triple antibody assay for the quantitation of plasma IgG subclass antibodies to acetylcholine receptors in patients with myasthenia gravis.
Nielsen FC; Rødgaard A; Djurup R; Somnier F; Gammeltoft S
J Immunol Methods; 1985 Nov; 83(2):249-58. PubMed ID: 3902978
[TBL] [Abstract][Full Text] [Related]
22. Search for cross-reactive idiotypes on monoclonal and myasthenia gravis acetylcholine receptor antibodies.
Roberts A; Lang B; Vincent A; Newsom-Davis J
Autoimmunity; 1992; 12(1):53-60. PubMed ID: 1617105
[TBL] [Abstract][Full Text] [Related]
23. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL;
BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795
[TBL] [Abstract][Full Text] [Related]
24. [The significance of determining antibodies to acetylcholine receptor in myasthenia gravis (author's transl)].
Toyka KV; Becker T; Fateh-Moghadam A; Besinger UA; Brehm G; Neumeier D; Heininger K; Birnberger KL
Klin Wochenschr; 1979 Sep; 57(18):937-42. PubMed ID: 502359
[TBL] [Abstract][Full Text] [Related]
25. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
[TBL] [Abstract][Full Text] [Related]
26. Measurement of human skeletal muscle acetylcholine receptor antibodies using monkey receptors.
Mickle DA; Wong PY; Humphrey JG; Griffith K; Mee AV
Clin Biochem; 1983 Jun; 16(3):163-6. PubMed ID: 6851078
[TBL] [Abstract][Full Text] [Related]
27. [Anti-acetylcholine receptor antibodies and myasthenia gravis (author's transl)].
Nishitani H
Nihon Naika Gakkai Zasshi; 1980 Dec; 69(12):1578-83. PubMed ID: 7229476
[No Abstract] [Full Text] [Related]
28. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity.
Besinger UA; Toyka KV; Hömberg M; Heininger K; Hohlfeld R; Fateh-Moghadam A
Neurology; 1983 Oct; 33(10):1316-21. PubMed ID: 6684226
[TBL] [Abstract][Full Text] [Related]
29. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
[TBL] [Abstract][Full Text] [Related]
30. [Acetylcholine receptor antibodies in the diagnosis of myasthenia gravis. Study of 406 confirmed cases].
Toyka KV; Heininger K
Dtsch Med Wochenschr; 1986 Sep; 111(38):1435-9. PubMed ID: 3757800
[TBL] [Abstract][Full Text] [Related]
31. [Acetylcholine receptor antibodies in myasthenia gravis. Measurement of plasma concentration by immunoprecipitation].
Gammeltoft S; Somnier FE
Ugeskr Laeger; 1984 Jan; 146(5):352-5. PubMed ID: 6372187
[No Abstract] [Full Text] [Related]
32. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients.
Dwyer DS; Bradley RJ; Urquhart CK; Kearney JF
Nature; 1983 Feb 17-23; 301(5901):611-4. PubMed ID: 6402708
[TBL] [Abstract][Full Text] [Related]
33. [Antibody against synthetic peptide corresponding to alpha-subunit residues 128-142 of nicotinic acetylcholine receptor (AChR): the significance in myasthenia gravis (MG)].
Shibuya N; Kanazawa H; Uyemura K
Rinsho Shinkeigaku; 1988 Mar; 28(3):315-9. PubMed ID: 3402139
[No Abstract] [Full Text] [Related]
34. [Assay of acetylcholine receptor antibodies in myasthenia gravis. A study of 329 sera (author's transl)].
Morel E; Raimond F; Goulon-Goëau C; Berrih S; Vernet-Der-Garabedian B; Harb J; Bach JF
Nouv Presse Med; 1982 May; 11(24):1849-54. PubMed ID: 7110933
[TBL] [Abstract][Full Text] [Related]
35. An enzyme-linked immunosorbent assay for antibody against acetylcholine receptor.
Hinman CL; Hudson RA; Burek CL; Goodlow G; Rauch HC
J Neurosci Methods; 1983 Oct; 9(2):141-55. PubMed ID: 6358708
[TBL] [Abstract][Full Text] [Related]
36. A practical enzyme immunoassay for anti-acetylcholine receptor antibodies in myasthenia gravis.
Furukawa S; Akazawa S; Furukawa Y; Kamo I; Satoyoshi E; Hayashi K
J Neuroimmunol; 1984; 6(6):397-409. PubMed ID: 6384263
[TBL] [Abstract][Full Text] [Related]
37. Correlation between myasthenia gravis-activities of daily living (MG-ADL) and quantitative myasthenia gravis (QMG) assessments of anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis in the phase 3 regain study.
Vissing J; O'Brien F; Wang JJ; Howard JF
Muscle Nerve; 2018 Aug; 58(2):E21-E22. PubMed ID: 29684239
[No Abstract] [Full Text] [Related]
38. Patient-specific anti=acetylcholine receptor antibody patterns in myasthenia gravis.
Savage-Marengo T; Harrison R; Lunt GG; Behan PO
J Neurol Neurosurg Psychiatry; 1980 Apr; 43(4):316-20. PubMed ID: 7373331
[TBL] [Abstract][Full Text] [Related]
39. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
40. The immunopathology of myasthenia gravis.
Lennon VA
Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
